Introduction {#H1-1-ZOI190416}
============

The proportion of Medicare beneficiaries enrolled in Medicare Advantage (MA) increased from 13% in 2004 to 33% in 2017.^[@zoi190416r1]^ Despite this growth, we know little about the quality of health care professionals serving MA beneficiaries compared with those serving traditional Medicare (TM) beneficiaries because of the incompleteness of MA claims data.

Both MA and TM beneficiaries use Medicare-certified home health (HH) services more than in the past. Between 2001 and 2015, Medicare spending for HH more than doubled to \$18 billion.^[@zoi190416r2]^ Of the 3.5 million^[@zoi190416r2]^ Medicare beneficiaries who receive HH annually, half are older than 75,^[@zoi190416r3]^ and all are homebound because of severe illness or functional limitation. The high risk of adverse outcomes in this vulnerable population^[@zoi190416r4]^ may be exacerbated by receiving care from low-quality home health agencies (HHAs).

The inability to assess the quality of HHAs serving MA beneficiaries is concerning. Although MA plans are required to cover the same minimum health care services as TM, MA beneficiaries receive care from their plan's network of preferred health care professionals and organizations, whereas TM beneficiaries may select any Medicare-certified health care professional and organization. Thus, similar to what has been observed in the private insurance market,^[@zoi190416r5],[@zoi190416r6],[@zoi190416r7]^ MA plans may form networks with lower-quality HHAs that are willing to accept lower prices.

The objective of the present study is to compare the quality of HHAs serving MA and TM beneficiaries. We used HH assessment data to overcome the absence of MA claims and compared publicly reported quality ratings of HHAs serving MA and TM beneficiaries.

Methods {#H1-2-ZOI190416}
=======

Study Design and Population {#H2-1-ZOI190416}
---------------------------

We conducted a cross-sectional, admission-level analysis of the association between Medicare type and HHA quality. We identified 5 071 922 Medicare HH admissions in 2015 by using Outcome and Assessment Information Set (OASIS) admission assessments. These assessments capture demographic and clinical data for all patients treated by Medicare- or Medicaid-certified HHAs. Admissions with missing data for any study variable were excluded, for a final sample of 4 391 980 admissions. There were more excluded admissions for MA (22.7%) than TM (9.8%) beneficiaries because of missing MA plan star ratings. In sensitivity analyses, thess omissions were not associated with our overall findings regarding differences in HHAs serving MA vs TM beneficiaries. Our analysis was conducted between October 2018 and March 2019. This study followed the Strengthening the Reporting of Observational Studies in Epidemiology ([STROBE](http://www.equator-network.org/reporting-guidelines/strobe/)) reporting guideline for cross-sectional studies. This study was approved by the institutional review board of Brown University, which also waived the need to obtain informed consent under 45 CFR 46 because the research involved no more than minimal risk to human participants, did not adversely affect the rights and welfare of the participants, and could not practicably be conducted without the waiver.

Outcome {#H2-2-ZOI190416}
-------

We used publicly reported quality of care star ratings, published on the Centers for Medicare & Medicaid Services HH Compare website^[@zoi190416r8]^ in July 2015 to represent HHA quality. The HHA star ratings summarize performance on 6 risk-adjusted outcome measures and 3 process-of-care measures.^[@zoi190416r9]^ Ratings are reported in half-star intervals ranging from 1 star (lowest quality) to 5 stars. We classified HHAs into 3 quality categories: low (1.0-2.5 stars), average (3.0-3.5 stars), and high (≥4.0 stars).

Explanatory Variable {#H2-3-ZOI190416}
--------------------

We classified beneficiaries as MA or TM based on enrollment status recorded in the Master Beneficiary Summary File. We further classified MA beneficiaries according to the quality of their MA plans by merging MA plan identifications obtained from the Healthcare Effectiveness Data and Information Set with publicly reported MA star ratings. Beneficiaries were assigned to 1 of 3 categories: TM, low-quality MA plan (1.0-3.5 stars), or high-quality MA plan (≥4.0 stars).

Covariates {#H2-4-ZOI190416}
----------

Analyses were adjusted for patient demographics, baseline function, prior conditions, and zip code characteristics ([Table 1](#zoi190416t1){ref-type="table"}) obtained from the Master Beneficiary Summary File, OASIS, and Centers for Medicare & Medicaid Services rural indicator file. To control for differential access to services, we determined the distance to the nearest low-, average-, and high-quality HHA by using ellipsoidal distances between the centroid of each patient's zip code and the centroid of the zip code of each HHA.

###### Characteristics of Medicare Home Health Patients by Plan Type

  Characteristic                                                                        No. (%) of Patients                    
  ------------------------------------------------------------------------------------- --------------------- ---------------- ----------------
  Total No.                                                                             3 316 163             344 684          731 133
  Patient characteristics                                                                                                      
  Age, mean (SD), y                                                                     76.1 (12.2)           74.4 (11.4)      77.8 (10.0)
  Female                                                                                2 037 932 (61.5)      216 671 (62.9)   454 451 (62.2)
  Race/ethnicity                                                                                                               
  Black                                                                                 423 432 (12.8)        71 596 (20.8)    82 898 (11.3)
  Other                                                                                 348 598 (10.5)        54 051 (15.7)    61 999 (8.5)
  Dual Medicare-Medicaid eligible                                                       1 010 355 (30.5)      149 291 (43.3)   142 384 (19.5)
  End-stage renal disease                                                               125 276 (3.8)         9457 (2.7)       16 776 (2.3)
  Home health use in year prior to admission                                            1 439 209 (43.4)      132 077 (38.3)   270 349 (37.0)
  Inpatient discharge in prior 2 wk[^a^](#zoi190416t1n1){ref-type="table-fn"}                                                  
  Nursing facility                                                                      28 199 (0.9)          2621 (0.8)       36 603 (0.8)
  SNF/transitional care unit                                                            523 848 (15.8)        51 770 (15.0)    142 082 (19.4)
  Acute care hospital                                                                   1 363 402 (41.1)      158 389 (46.0)   344 356 (47.1)
  Long-term care hospital                                                               21 033 (0.6)          2114 (0.6)       3654 (0.5)
  Inpatient rehabilitation facility                                                     232 282 (7.0)         24 594 (7.1)     42 026 (5.8)
  Psychiatric facility                                                                  11 003 (0.3)          851 (0.3)        1503 (0.2)
  Other                                                                                 10 206 (0.3)          1107 (0.3)       3127 (0.4)
  Prior conditions[^a^](#zoi190416t1n1){ref-type="table-fn"}                                                                   
  Urinary incontinence                                                                  1 255 067 (37.9)      116 832 (33.9)   255 033 (34.9)
  Catheter                                                                              67 380 (2.0)          6458 (1.9)       14 903 (2.0)
  Intractable pain                                                                      489 173 (14.8)        46 891 (13.6)    99 805 (13.7)
  Impaired decisions                                                                    633 500 (19.1)        55 201 (16.0)    118 155 (16.2)
  Disruptive behavior                                                                   58 331 (1.8)          4600 (1.3)       9753 (1.3)
  Memory loss                                                                           434 292 (13.1)        35 067 (10.2)    90 278 (12.4)
  Ventilator use                                                                        3607 (0.1)            326 (0.1)        536 (0.1)
  Functional scale score, mean (SD)[^b^](#zoi190416t1n2){ref-type="table-fn"}           3.3 (1.4)             3.1 (1.4)        3.1 (1.4)
  Characteristic by patient zip code, mean (SD)                                                                                
  Distance to nearest HHA by quality, miles[^c^](#zoi190416t1n3){ref-type="table-fn"}                                          
  Low                                                                                   40.2 (184.1)          39.4 (202.3)     31.0 (170.6)
  Average                                                                               8.2 (32.7)            7.7 (33.9)       7.1 (25.2)
  High                                                                                  35.1 (159.7)          40.4 (175.3)     36.7 (172.7)
  \% Dual Medicare-Medicaid eligible in zip code                                        24.4 (12.0)           27.4 (12.8)      23.7 (11.2)
  Zip code MA penetration                                                               28.4 (1.3)            33.8 (12.4)      37.8 (13.3)
  Rural county, %                                                                       18.1                  15.4             12.6

Abbreviations: HHA, home health agency; MA, Medicare Advantage; OASIS, Outcome and Assessment Information Set; SNF, skilled nursing facility; TM, traditional Medicare.

Inpatient discharge and prior conditions are identified using check boxes in the OASIS assessments.

Represents performance across OASIS function items. Possible scores range from 0 to 8, with 0 representing complete independence and 8 indicating inability to a complete tasks such as ambulation, transferring, and grooming.

To convert miles to kilometers, multipy by 1.6.

Statistical Analysis {#H2-5-ZOI190416}
--------------------

We used multinomial logistic regression with zip code--clustered errors to assess the association between Medicare plan type and HHA quality. To facilitate interpretation, we present the marginal effect of MA plan type on HHA quality. This was interpreted as the absolute difference in the probability of receiving care from a low- or high-quality HHA if a patient enrolled in a low- or high-quality MA plan instead of TM, holding other characteristics constant.

We were unable to use zip code fixed effects in a multinomial model; therefore, we could not fully account for differences by neighborhood, which may be associated with patient selection and outcomes.^[@zoi190416r10],[@zoi190416r11]^ We conducted sensitivity analyses using separate linear regression models (one with the outcome high-quality HHA and one with the outcome low-quality HHA) and controlled for zip code fixed effects and patient characteristics. Analyses were conducted using Stata, version 14 (StataCorp LLC).

Results {#H1-3-ZOI190416}
=======

[Table 1](#zoi190416t1){ref-type="table"} gives the characteristics of the study population stratified by Medicare plan type. The majority (75.5%) of admissions were for TM beneficiaries (mean \[SD\] age, 76.1 \[12.2\] years), whereas 16.6% of beneficiaries were enrolled in the high-quality MA plan (mean \[SD\] age, 77.8 \[10.0\] years) and 7.9% in the low-quality MA plans (mean \[SD\] age, 74.4 \[11.4\] years). Individuals enrolled in low-rated MA plans were most likely to be nonwhite (14.3% of TM beneficiaries, 19.8% in high-quality MA plans, and 36.5% in low-quality MA plans) and dual Medicare-Medicaid eligible (30.5% of TM beneficiaries, 19.5% in high-quality MA plans, and 43.3% in low-quality MA plans).

The [Figure](#zoi190416f1){ref-type="fig"} uses polynomial regression curves to display the rate of high-quality HHA use in association with individuals' distances to the nearest high-quality HHA across Medicare plan types. The TM beneficiaries were more likely than both types of MA beneficiaries from the same neighborhood to receive care from a high-quality HHA. Differences across plan types decreased as distance to the nearest high-quality HHA increased, suggesting that if a high-quality HHA is too far, all residents are unlikely to receive high-quality HHA care.

![Rate of Treatment From a High-Quality Home Health Agency (HHA) by Distance to Nearest High-Quality Agency Across Medicare Plan Types\
High-quality HHAs receive 4 to 5 stars. Shading indicates 95% CIs. To convert miles to kilometers, multipy by 1.6. MA indicates Medicare Advantage; TM, traditional Medicare.](jamanetwopen-2-e1910622-g001){#zoi190416f1}

Among TM beneficiaries, the proportion receiving care from low-quality HHAs was 17.0%, and the proportion receiving care from high-quality HHAs was 30.4% ([Table 2](#zoi190416t2){ref-type="table"}). After adjustment using multinomial logistic regression, compared with TM beneficiaries, those in a low-quality MA plan were 3.0 percentage points (95% CI, 2.6%-3.4%) more likely to be treated by a low-quality HHA and 4.9 percentage points (95% CI, −5.4% to −4.3%) less likely to be treated by a high-quality HHA. The MA beneficiaries in high-quality plans were also less likely to receive care from high-quality HHAs, although the magnitude of the difference from TM was smaller (adjusted difference in likelihood of treatment from low-quality HHA, 1.0% \[95% CI, 0.7%-1.3% vs adjusted difference in treatment from high-quality HHA, −2.8% \[95% CI, −3.1% to −2.2%\]).

###### Association Between Medicare Plan Type and Changes in Rate of Treatment by Low- and High-Quality HHAs

  Quality of HHA    TM, Distribution, %   Low-Quality MA Plan   High-Quality MA Plan                                                                                    
  ----------------- --------------------- --------------------- ---------------------- --------------------- --------------------- ------ ------- --------------------- ---------------------
  Low, \<3 stars    17.0                  23.5                  6.50                   3.0 (2.6 to 3.4)      2.3 (2.2 to 2.4)      18.3   1.30    1.0 (0.7 to 1.3)      2.2 (2.1 to 2.3)
  High, 4-5 stars   30.4                  22.6                  −7.80                  −4.9 (−5.4 to −4.3)   −2.0 (−2.2 to −1.9)   27.0   −3.40   −2.8 (−3.1 to −2.2)   −3.1 (−3.2 to −3.0)

Abbreviations: HHAs, home health agencies; MA, Medicare Advantage; TM, traditional Medicare.

Represents the marginal effects of our multinomial regression model assessing the association between Medicare plan type and quality of treating HHA. The model was adjusted for all variables listed in Table 1, and confidence intervals were clustered on zip code.

Represents estimates of the linear regression models (one with the outcome high-quality HHA and one with the outcome low-quality HHA). The linear models were adjusted for all patient characteristics listed in Table 1 as well as for zip code fixed effects.

After adjustment using linear regression models with zip code fixed effects, MA enrollees overall remained less likely than TM enrollees to receive care from high-quality HHAs. However, differences within MA enrollees by plan type were either eliminated or inverted. Compared with TM, the low-quality MA adjusted difference in likelihood of treatment from a low-quality HHA was 2.3% (95% CI, 2.2%-2.4%), and the adjusted difference in treatment from a high-quality HHA was −2.0% (95% CI, −2.2% to −1.9%). Compared with TM, the high-quality MA adjusted difference in likelihood of treatment from a low-quality HHA was 2.2% (95% CI, 2.1%-2.3%), and the adjusted difference in treatment from a high-quality HHA was −3.1% (95% CI, −3.2% to −3.0).

Discussion {#H1-4-ZOI190416}
==========

We found that MA enrollees were less likely to receive care from high-quality HHAs compared with their TM counterparts. We did not find that individuals enrolled in low-rated MA plans, who were more likely to be nonwhite and enrolled in Medicaid, received lower-quality HH care compared with individuals enrolled in high-quality MA plans after controlling for zip code. However, lower HHA quality for MA enrollees overall raises concerns about potential disparities in access to high-quality HH care and is consistent with prior research documenting greater use of low-quality skilled nursing facilities in the MA program.^[@zoi190416r12]^

Lower HH quality for MA beneficiaries may be attributable to plans' narrow HHA networks, which may include low-quality HHAs that are willing to accept lower prices. In fact, HHAs are excluded from MA network adequacy criteria.^[@zoi190416r13]^ Revisions to these criteria may incentivize MA plans to expand networks and increase access to higher-quality HHAs. In addition, patient education and reforms in the acute discharge planning process may improve access to and information about postacute care quality for HH.^[@zoi190416r14],[@zoi190416r15],[@zoi190416r16]^

Whether or not lower-quality HH or other postacute care translates to worse outcomes for MA enrollees is uncertain. The MA plans have strong incentives to coordinate care for enrollees because they receive capitated per beneficiary payments from Medicare. However, if MA enrollees are healthier or receive better care elsewhere, then MA plans may invest less in HH care. In addition, findings across studies examining TM and MA differences in patients' posthospital outcomes are inconsistent and have not focused on patients receiving HH care.^[@zoi190416r17],[@zoi190416r18],[@zoi190416r19]^

Limitations {#H2-6-ZOI190416}
-----------

The present study had several limitations. We did not control for MA plan structure (eg, health maintenance organization vs preferred provider organization). In addition, we could not observe the HHA selection process and thus could not determine the primary mechanisms behind differences in HHA quality by plan type. Star ratings may not adequately capture quality of care, and the reliability and validity of these measures have been questioned.^[@zoi190416r20]^ For example, a study showed that the rank ordering of facilities is sensitive to changes in risk adjustment methods.^[@zoi190416r21]^ Although a recent rigorously designed study found that nursing homes with higher star ratings provide better quality care,^[@zoi190416r22]^ future research that assesses the adequacy of home health star ratings is needed. Despite these limitations, our findings represent novel evidence regarding HHA quality by Medicare plan type during a time of substantial growth in both the MA and HH populations.

Conclusions {#H1-5-ZOI190416}
===========

The present study results indicated that compared with their TM counterparts, MA beneficiaries received treatment from lower-quality HHAs. Policy makers may consider incentivizing MA plans to include higher-quality HHAs in their preferred HHA networks and improving patient education regarding HHA quality.
